Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL001094

Drug Information
NameAP23573    
SynonymsDeforolimus (USAN); AP-23573; D08900; AP 23573; Deforolimus; S1022_Selleck; Ridaforolimus; MK 8669; MK-8669; 42-(Dimethylphosphinate)rapamycin; 572924-54-0; AP23573, MK-8669, Ridaforolimus, Deforolimus    
CompanyMerck/Ariad    
IndicationMetastatic Soft-Tissue Sarcomas; Metastatic Bone SarcomasPhase III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
FormularC53H84NO14P    
PubChem Compound IDCID 23724531.    
PubChem Substance IDSID 17396180.    
ClinicalTrials.govNCT00538239;    
TargetSerine/threonine-protein kinase mTORInhibitor[1]
Ref 1Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009 Aug;8(8):627-44. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543